Therapy Areas: Allergy
19 September 2017 - - Yardley, Pennsylvania-based otolaryngology and allergy therapeutics developer Optinose has received approval from the US Food and Drug Administration (FDA) of its New Drug Applic...
15 September 2017 - ALK-Abelló A/S (ALK)(CPH:ALKB), a research-driven global pharmaceutical company focusing on allergy prevention, diagnosis and treatment, reported on Thursday the successful ...
14 September 2017 - - The global pulmonary drug delivery devices/systems market is expected to reach USD 55.1bn by 2025, according to a new report by US based market research and consul...
14 September 2017 - - US-based antibiotic developer Geom Therapeutics, Inc. has signed a clinical trial agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the Na...
11 September 2017 - - US-based late clinical-stage biopharmaceutical company Zavante Therapeutics, Inc. has signed a clinical trial agreement with the National Institute of Allergy and Infectious Dise...
11 September 2017 - - US-based late clinical-stage biopharmaceutical company Zavante Therapeutics, Inc. has signed a clinical trial agreement with the National Institute of Allergy and Infectious Dise...